Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
06946471
ABSTRACT:
This invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and cancer related diseases.
REFERENCES:
patent: WO 96/18626 (1996-06-01), None
patent: WO 01/44154 (2001-06-01), None
Gust et al., Eur. J. Med. Chem., 28, pp. 103-115 (1993).
Somei et al., Chem. Pharm. Bull., 29, pp. 3145-3157 (1981).
Karl et al., J. Med. Chem., 31., pp. 72-83 (1988).
Leeper et al., Pestic. Chem., Proc. Int. Congr. Pestic. Chem. 2nd, Tahoori, A. (Ed.) 5, pp. 125-139 (1972).
Brandt Michael
Fertig Georg
Krell Hans-Willi
von Hirschheydt Thomas
Voss Edgar
Hoffmann-La Roche Inc.
Johnston George W.
Raymond Richard L.
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
2-(2,6-Dichlorophenyl)-Diarylimidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(2,6-Dichlorophenyl)-Diarylimidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(2,6-Dichlorophenyl)-Diarylimidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3434269